vHive Launches Real-Time Solution to Validate As-Built Installations for MNOs

vHive Launches Real-Time Solution to Validate As-Built Installations for MNOs

NEW YORK, Dec. 3, 2025 /PRNewswire/ -- vHive, a global leader in infrastructure digitization, announces the launch of On-Site Validation, the first real-time field verification solution that ensures antenna installations match modification plans...

A New Chapter in Bilingual Excellence: YK Pao School Hong Kong Appoints its Founding Head

A New Chapter in Bilingual Excellence: YK Pao School Hong Kong Appoints its Founding Head

HONG KONG, Dec. 3, 2025 /PRNewswire/ -- In a significant milestone in its founding, YK Pao School Hong Kong today announces the appointment of Mrs. Cathy Braithwaite as its Founding Head. This appointment marks the next step in realising a visionary...

Beep Receives Frost & Sullivan's 2025 North American Technology Innovation Leadership Recognition for Excellence in Scalable, Service-Oriented Autonomous Mobility Solutions

Beep Receives Frost & Sullivan's 2025 North American Technology Innovation Leadership Recognition for Excellence in Scalable, Service-Oriented Autonomous Mobility Solutions

Beep is honored for combining innovation, operational efficiency, and customer trust to advance autonomous shuttle adoption across public and private transit networks SAN ANTONIO, Dec. 3, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to...

Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®

Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®

FDA approval of OMLYCLO® (omalizumab-igec) 300 mg/2 mL solution in a single-dose prefilled syringe for subcutaneous injection expands dosing flexibility and supports tailored treatment for individual patients with certain allergic diseases OMLYCLO®...

Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities

Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities

SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and...

Cellid Announces Two New Reference Designs for Next-Generation AR Glasses

Cellid Announces Two New Reference Designs for Next-Generation AR Glasses

Cutting-edge wireless AR glasses enabled by proprietary optical technology and the latest waveguide innovations TOKYO, Dec. 2, 2025 /PRNewswire/ -- Cellid Inc., a developer of displays and spatial recognition engines for next-generation AR glasses,...

Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines...

TP Receives Frost & Sullivan's 2025 African Company of the Year Recognition for Excellence in the Outsourcing Industry

TP Receives Frost & Sullivan's 2025 African Company of the Year Recognition for Excellence in the Outsourcing Industry

TP recognized for advancing Africa's outsourcing landscape through its strategic integration of technology, emotional intelligence, and sustainable growth initiatives. SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to...

IMS Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Connected and Telematics Insurance

IMS Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Connected and Telematics Insurance

Recognized for driving innovation in connected insurance and telematics solutions, IMS demonstrates leadership in customer engagement, data-driven insights, and digital transformation SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is...

InSkill Receives Frost and Sullivan's 2025 Global New Product Innovation Recognition for Its Industrial AI Copilot Platform

InSkill Receives Frost and Sullivan's 2025 Global New Product Innovation Recognition for Its Industrial AI Copilot Platform

The company is honored for advancing industrial performance with GenAI copilots that improve equipment uptime, boost worker productivity, and streamline knowledge capture across industrial operations. SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost...

  • 1
  • ...
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • ...
  • 160
  • menu
    menu